Computational dissection and prediction of cancer immunotherapy response
Checkpoint blockade immunotherapies have transformed the standard of care and outcomes for many cancer types; however. more than 60% of patients still do not experience a durable clinical response from these treatments. To address this problem, the development of novel biomarkers and more effective...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Published: |
Massachusetts Institute of Technology
2022
|
| Online Access: | https://hdl.handle.net/1721.1/139899 |